The combined vaccine elicited higher immune response against SARS-CoV-2.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
A rapid review and meta-analysis of studies involving more than 35,000 COVID-19 patients has found that three-quarters received antibiotics even though fewer than 10% had a bacterial co-infection, Canadian researchers reported today in Clinical Microbiology and Infection.
Also, Florida and New York confirm their first cases involving the UK variant.
The country's third lockdown will last till at least mid-February.
The phase 3 clinical studies indicate good safety, efficacy for both Moderna and Pfizer vaccines.
Interim study results published late last week in Morbidity and Mortality Weekly Report (MMWR) found that only 19% of people exposed to a COVID-19 patient in their home who had no symptoms nor a positive test result in the first 7 days of the patient's illness later tested positive—lending support for recently changed Centers for Disease Control and Prevention (CDC) guidelines.
"Hospitals are becoming overwhelmed with more patients than can be managed with typical care standards."
Impaired cognition and physical impairment were both tied to higher death rates.
As labs rush to determine variant prevalence, the CDC warns it could put more pressure on US hospitals.
An Italian study in the Journal of Antimicrobial Chemotherapy yesterday found that 21.9% of hospitalized COVID-19 patients acquired bacterial or fungal superinfections—infection by a secondary pathogen—that complicated the course of their recovery.
On top of general hesitancy, vaccine attitudes reflected concerns about government interference in the process, including with scientific evaluation.
